Preparation of chitosan derivative micelles containing cyclosporine A and its oral bioavailability in rats

Journal of China Pharmaceutical University

Volumn 38, Issue 3, 2007, Pages 208-212

  Liu, Lei ^a   Ping, Qi Neng ^a   Zhang, Can ^a   Liu, Min Xia ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Cyclosporine A; Micelles; N octyl O sulfate chitosan; Oral bioavailability

Indexed keywords

CHITOSAN DERIVATIVE; CYCLOSPORIN A; SOLVENT;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; COMPARTMENT MODEL; COMPUTER PROGRAM; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; DRUG SOLUBILITY; EMULSION; ENCAPSULATION; EVAPORATION; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; MICELLE; NONHUMAN; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TIME TO MAXIMUM PLASMA CONCENTRATION;

EID: 34447137032     PISSN: 10005048     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Laupacis A, Keown PA, Ulan RA, et al. Cyclosporine A: a powerful immunosuppressant[J]. Can Med Assoc J, 1982, 126(9):1041-1046.
2. Yee GC, McGuire TR. Pharmacokinetic drug interactions with cyclosporine (part I) [J]. Clin Pharmacokinet, 1990, 19(4):319-322.
3. Hauer B, Meinzer A, Posanski U, et al. Oral pharmaceutical compositions containing cyclosporine A: FR, FR2678169 [P]. 1992-12-31.
4. Lukyanov AN, Torchilin VP. Micelles from lipid derivatives of water-soluble polymers as delivery system for poorly soluble drugs [J]. Adv Drug Deliv Rev, 2004, 56(9):1273-1289.
5. Francis MF, Lavoie L, Winnik EM, et al. Solubilization of cyclosporine A in dextran-g-polyethyleneglycolalkyl ether polymeric micelles [J]. Eur J Pharm Biopharm, 2003, 56(1):337-346.
6. Zhang C, Qineng P, Zhang H. Self-assembly and characterization of paclitaxel-loaded N-octyl-O-sulfate chitosan micellar system [J]. Colloids Surf B Biointerfaces, 2004, 39(1):69-75.
7. Chinese source.
8. Yua BG, Okanob T, Kataoka K, et al. Polymeric micelles for drug delivery: solubilization and haemolytic activity of amphotericin B [J]. J Control Release, 1998, 53(1-3):131-136.
9. Afsaneh Lavasanifar, John Samuel, Glen SK. Micelles self-assembled from poly (ethylene oxide)-block-poly (N-hexyl stearate L-aspartamide) by a solvent evaporation method: effect on the solubilization and haemolytic activity of amphotericin B [J]. J Control Release, 2001, 77(1-2):155-160.
10. Guo JX, Ping QN, Wu T. J China Pharm Univ, 2000, 31(5):340-343.
11. Li Y, Zhu KJ, Zhang JX, et al. In vitro and in vivo studies of cyclosporine A-loaded microspheres based on copolymers of lactide and ε-caprolactone: comparison with conventional PLGA microspheres [J]. Int J Pharm, 2005, 295(1-2):67-76.
12. Si LQ, Sun MH, He XX. China Pharm, 2005, 8(5):363-366.
13. Wang XQ, Zhang T, Zhang Q. Acta Pharm Sin, 2004, 39(6):463-466.
14. Mira FF, Luc Lavoie, Francoise MW, et al. Solubilization of cyclosporine A in dextran-g-polyethyleneglycolalkyl ether polymeric micelles [J]. Eur J Pharm Biopharm, 2003, 56(3):337-346.
15. Huo MR, Zhou JP, Wei Y, China Pharm Univ, 2006, 37 (2):132-136.
16. Avadi MR, Jalali A, Sadeghi AM, et al. Methyl methyl chitosan as an intestinal paracellular enhancer: ex vivo and in vivo studies [J]. Int J Pharm, 2005, 293(1-2):83-89.
17. Cornaire G, Woodley J, Hermann P, et al. Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo [J]. Int J Pharm, 2004, 278(1):119-131.